SAVANNAH, Ga. — Should patients with myasthenia gravis (MG) continue to undergo the traditional therapy of immunosuppression with drugs like corticosteroids and nonsteroidal agents? Or is it time to ...

Drooping eyelids, referred to as ptosis, are a common symptom of myasthenia gravis. The disease can weaken muscles around the eye, as well as muscles involved with walking, breathing, and more.

The first study to use an RNA-based chimeric antigen receptor T-cell (rCAR-T) therapy in autoimmune disease showed people with generalized myasthenia gravis tolerated the treatment well and ...

Myasthenia gravis develops when the body produces autoantibodies that interfere with the way nerves and muscles communicate. The disease can lead to severe attacks of weakness that cause swallowing ...

Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of ...

Positive topline results from two phase 3 trials reported this week may expand the treatment landscape for generalized myasthenia gravis (gMG), a rare autoimmune disease marked by debilitating muscle ...

Myasthenia gravis is a chronic autoimmune disorder that disrupts nerve-to-muscle signaling, causing weakness. Modern treatments help many people live typical life spans and enter remission.

Acupuncture may help reduce symptoms and improve overall quality of life when used as a complementary therapy for myasthenia gravis (MG), but further research is needed to explore its effectiveness.

It’s a lifelong autoimmune neuromuscular disease. It causes certain muscles to weaken easily after you use them. Muscle fatigue typically varies throughout the day (sometimes hour by hour) and gets ...